Evidence map›Paper›PMID 30060607›Full record

ArticleMolecules (Basel, Switzerland)2018

Comprehensive Snake Venomics of the Okinawa Habu Pit Viper,

Maik Damm, Benjamin-Florian Hempel, Ayse Nalbantsoy, Roderich D Süssmuth

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells.Environmental analysis, health and toxicology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Biochemical and proteomic analyses of venom from a new pit viper,The journal of venomous animals and toxins including tropical diseases · 2022
    Article
  10. Review
  11. Cytotoxic and anticancer properties of the Malaysian mangrove pit viper (The journal of venomous animals and toxins including tropical diseases · 2020
    Article
  12. Article
  13. Venomics ofToxins · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Maik DammInstitut für Chemie, Technische Universität Berlin, 10623 Berlin, Germany. maik.damm@tu-berlin.de.ORCID 0000-0003-0810-3699
Benjamin-Florian HempelInstitut für Chemie, Technische Universität Berlin, 10623 Berlin, Germany. benjamin.hempel@chem.tu-berlin.de.ORCID 0000-0002-1998-4033
Ayse NalbantsoyDepartment of Bioengineering, Ege University, 35100 Izmir, Turkey. analbantsoy@gmail.com.ORCID 0000-0002-3852-1974
Roderich D SüssmuthInstitut für Chemie, Technische Universität Berlin, 10623 Berlin, Germany. suessmuth@chem.tu-berlin.de.ORCID 0000-0001-7027-2069
Technische Universität Berlin · DEEge University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Asian world is home to a multitude of venomous and dangerous snakes, which are used to induce various medical effects in the preparation of traditional snake tinctures and alcoholics, like the Japanese snake wine, named Habushu. The aim of this work was to perform the first quantitative proteomic analysis of the

Indexed as

5'-NucleotidaseAnimalsAntineoplastic AgentsCell Line, TumorCell SurvivalChemical FractionationChromatography, High Pressure LiquidCrotalid VenomsDisintegrinsHumansInhibitory Concentration 50IsoenzymesL-Amino Acid OxidaseLectins, C-TypeMass SpectrometryMetalloproteases5'-NucleotidaseAntineoplastic AgentsCrotalid VenomsDisintegrinsIsoenzymesL-Amino Acid OxidaseLectins, C-TypeMetalloproteasesOligopeptidesPhospholipases A2Phosphoric Diester HydrolasesSerine Proteasesbottom-upBPPcytotoxicityHabu pit viperProtobothrops flavoviridissnake venomicstop-downtripeptide metalloprotease inhibitorviperidae

Identifiers

PMID30060607
PMCPMC6222445
OpenAlexW2825746406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.